-+ 0.00%
-+ 0.00%
-+ 0.00%

Becle, S.A.B. de C.V. Just Missed EPS By 36%: Here's What Analysts Think Will Happen Next

Simply Wall St·10/31/2026 14:09:12
Listen to the news

Becle, S.A.B. de C.V. (BMV:CUERVO) missed earnings with its latest third-quarter results, disappointing overly-optimistic forecasters. It wasn't a great result overall - while revenue fell marginally short of analyst estimates at Mex$9.3b, statutory earnings missed forecasts by an incredible 36%, coming in at just Mex$0.18 per share. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

earnings-and-revenue-growth
BMV:CUERVO * Earnings and Revenue Growth October 31st 2026

After the latest results, the eight analysts covering Becle. de are now predicting revenues of Mex$42.2b in 2027. If met, this would reflect a solid 12% improvement in revenue compared to the last 12 months. Per-share earnings are expected to surge 21% to Mex$1.28. Before this earnings report, the analysts had been forecasting revenues of Mex$41.9b and earnings per share (EPS) of Mex$1.28 in 2027. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

View our latest analysis for Becle. de

It will come as no surprise then, to learn that the consensus price target is largely unchanged at Mex$18.38. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. There are some variant perceptions on Becle. de, with the most bullish analyst valuing it at Mex$34.00 and the most bearish at Mex$12.00 per share. With such a wide range in price targets, analysts are almost certainly betting on widely divergent outcomes in the underlying business. With this in mind, we wouldn't rely too heavily the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. For example, we noticed that Becle. de's rate of growth is expected to accelerate meaningfully, with revenues forecast to exhibit 9.7% growth to the end of 2027 on an annualised basis. That is well above its historical decline of 0.2% a year over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in the industry are forecast to see their revenue grow 6.1% per year. So it looks like Becle. de is expected to grow faster than its competitors, at least for a while.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Becle. de analysts - going out to 2028, and you can see them free on our platform here.

Before you take the next step you should know about the 3 warning signs for Becle. de that we have uncovered.